References
- Sniderman AD, Blank D, Zakarian R, Bergeron J, Frolich J. Triglycerides and small dense LDL: the twin Achilles heel of the Friedewald formula. Clin Biochem 2003; 36: 499–504.
- Expert panel on petection, evaluation and treat-ment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–96.
- Cui Y, Blumenthal RS, Flaws JA, Whiteman M, Langemberg P, Bachorik PS, Bush TL. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001; 161: 1413–9.
- Lu W, Resnick H, Jablonsky K, Jones KL, Jain AK, Howard WJ, Robbins DC, Howard BY. Non-HDL cholesterol as a predictor of cardio-vascular disease in type 2 diabetes: the Strong Heart Study. Diabetes Care 2003; 26: 16–23.
- Hsia SH. Non-HDL cholesterol: into the spotlight. Diabetes Care 2003; 26: 240–2.
- Schamagl H, Nauck M, Wieland H, Marz W. The Friedewald formula underestimates LDL choles-terol at low concentrations. Clin Chem Lab Med 2001; 39: 426–31.
- Rossetti L, Goldberg U. A new piece in the diabetes puzzle. Nature Med 2002; 8: 112–4.
- Durrington PN. Can measurement of apolipo-protein B replace the lipid profile in the follow-up of patients with lipoprotein disorders? Clin Chem 2002; 48: 401–2.
- Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frolich J, Jungner I, Walldius G. Apolipoproteins versus lipids as indices of coro-nary risk and as targets for statin treatment. Lancet 2003; 361: 777–80.
- Williams K, Sniderman AD, Sattar N, D'Agostino Jr R, Wagenknecht LE, Haffner SM. Comparison of the association of apolipoprotein B and low-density lipoprotein cholesterol with other cardio-vascular risk factors in the insulin resistance atherosclerosis study (IRAS). Circulation 2003; 108: 2312–6.
- Sniderman AD, St-Pierre AC, Cantin B, Dagenais GR, Després J-P, Lamarche B. Concordance/ discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. Am J Cardiol 2003; 91: 1173–7.